In addition to delivering excellence in teaching and clinical care, members of our Division are international leaders in microbial pathogenesis, immunology, and global and public health. Our investigators are recognized for their ground breaking discoveries from basic microbial pathogenesis and host defense to translational and clinical infectious disease research and implementation science. From model systems to human studies, we are making cutting edge discoveries and translating the latest knowledge into improvements in human health. We work in a highly collaborative environment that fosters rapid uptake of new technology and has a well-developed infrastructure that supports basic investigation and a pipeline to translational and clinical studies. Available resources include biosafety level 3 (BSL3) facilities and many outstanding core facilities, including those for genomics, imaging, genome engineering, and Cryo-EM. We attract top trainees and investigators, are highly successful competing for federal, foundation, and philanthropic funding, and seek to be transformative to human health. Read recent publications.
The Division of Infectious Diseases was supported by more than $50 million in external funds in 2021. Sources of funding include:
Multidisciplinary training is supported by:
- National Institutes of Health (NIH)
- Research Grants, Career Development Awards, Program Project/Center Grants
- T32 Infectious Disease/Basic Microbial Pathogenic Mechanisms Training Grant
- K12 Multidisciplinary Clinical Research Career Development Program (MCRCDP)
- Centers for Disease Control and Prevention (CDC)
- Agency for Healthcare Research and Quality (AHRQ)
- Bill and Melinda Gates Foundation
- The Medical Scientist Training Program (MSTP) at Washington University, the largest MD/PhD program in the country.
Explore the division’s clinical and basic research enterprises below and the faculty involved in each science category with their particular interests.